Property:RefDocPart
From GxPlex
Article, annex, or section this reference covers.
G
Part 1
Article 2 +
E
Preamble +
U
USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020 Q15 +
Q15 +
E
F
FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 R1123-46 +
R1123-46 +
FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 R1123-53 +
R1123-53 +
G
Schedule 1
Part 2 +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 10. +
Schedule 1
Part 2
10. +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 12. +
Schedule 1
Part 2
12. +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 16. +
Schedule 1
Part 2
16. +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 6. +
Schedule 1
Part 2
6. +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 7 +
Schedule 1
Part 2
7 +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 3-001 +
Schedule 1
Part 3 +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 3-002 +
Schedule 1
Part 3 +
Schedule 1
Part 4 +
Schedule 1
Part 5 +